Skip to main content
Chemomab Therapeutics Ltd. logo

Chemomab Therapeutics Ltd. — Investor Relations & Filings

Ticker · CMMB ISIN · US16385C1045 US Manufacturing
Open in API
Filings indexed 332 across all filing types
Latest filing 2021-02-11 Regulatory Filings
Country US United States of America
Listing US CMMB

About Chemomab Therapeutics Ltd.

https://www.chemomab.com/

Chemomab Therapeutics Ltd. is a clinical-stage biotechnology company developing therapeutics for fibro-inflammatory diseases with high unmet medical needs. The company's scientific platform is based on the discovery of the soluble protein CCL24's central role in driving the cycle of fibrosis and inflammation. Its lead product candidate, nebokitug (CM-101), is a first-in-class monoclonal antibody designed to neutralize CCL24, thereby interfering with the primary pathways that promote these conditions. Nebokitug has demonstrated disease-modifying potential in multiple clinical trials and has received Orphan Drug and Fast Track designations from the U.S. FDA for the treatment of primary sclerosing cholangitis (PSC). Following positive Phase 2 results, the company is preparing for a potential Phase 3 trial for nebokitug in PSC.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2021
Regulatory Filings
2021-02-11 English
Regulatory Filings 2021
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the SEC Division of Corporation Finance requesting acceleration of the effective date of a Registration Statement on Form S-4. It is a formal regulatory communication related to a securities filing, specifically concerning the timing of the effectiveness of a registration statement. The document is short (1701 characters) and does not contain financial data, report content, or detailed disclosures. It is a regulatory filing related to the registration process rather than a financial report or announcement of results. Therefore, it fits best under Regulatory Filings (RNS).
2021-02-10 English
Regulatory Filings 2021
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the SEC Division of Corporation Finance requesting acceleration of the effective date of a Registration Statement on Form S-4. It is a formal regulatory communication related to a securities registration process, specifically concerning the timing of the effectiveness of a filing. The document does not contain financial statements, audit information, or detailed report content. It is a regulatory filing related to the registration process and acceleration request, not a full report or announcement of financial results. Therefore, it fits best under Regulatory Filings (RNS). The document length is short (1701 characters), consistent with a regulatory filing letter rather than a full report.
2021-02-10 English
S-4/A
Merger & Acquisition Classification · 95% confidence The document is an Amendment No. 1 to Form S-4 Registration Statement filed with the SEC, which is used for registering securities in connection with mergers and acquisitions. The text references a merger agreement, issuance of shares, proxy statement/prospectus, and shareholder meeting to approve the merger and related transactions. It includes detailed information about the merger, share issuance, amendments to articles of association, indemnification agreements, and compensation policies. The document is clearly related to merger and acquisition activities and includes proxy solicitation materials for shareholder approval. Therefore, the document fits best under the category of Merger & Acquisition filings (MA). The document length and content indicate it is the filing itself, not just an announcement or proxy solicitation alone, so it is not PSI or RPA. Hence, the classification is MA with high confidence.
2021-02-10 English
FORM 8-K
Merger & Acquisition Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content focuses on announcing a Special Meeting of Shareholders to approve a merger, including details about the merger agreement, proxy statement, and related corporate actions. It also includes forward-looking statements and instructions on where to find the proxy statement and other filings. The document does not contain full financial statements or detailed financial analysis but is primarily an announcement of a corporate event and solicitation of shareholder votes related to a merger. This fits the category of a Merger & Acquisition (MA) filing, as it relates to merger communications and proxy solicitation for merger approval. The document is not a full proxy statement itself but an 8-K current report announcing the event and related information, which aligns with the MA category for merger-related filings.
2021-02-08 English
425 Filing
Merger & Acquisition Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content focuses on announcing a Special Meeting of Shareholders to approve a merger, including details about the merger agreement, proxy statement, and related shareholder voting matters. It also includes forward-looking statements and references to other filings such as proxy statements and registration statements. The document does not contain full financial statements or detailed financial analysis, nor is it a transcript, audit report, or earnings release. It is primarily an announcement of a corporate event related to merger and shareholder meeting. Given the detailed description of the merger and solicitation of shareholder approval, this filing best fits the category of Merger & Acquisition (MA) filings, which include merger communications and related proxy materials. The document is not a proxy statement itself but a current report announcing the merger and related shareholder meeting. Therefore, the classification is MA with high confidence.
2021-02-08 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.